Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

This study is testing a long-acting injectable form of PrEP (pre-exposure prophylaxis) called cabotegravir for people who inject drugs and are at risk of HIV. Instead of a daily pill, cabotegravir is given as an injection every 2 months to help prevent HIV infection. **You may be eligible if...** - You are 18 or older - You have injected non-prescribed drugs in the past 6 months - You tested HIV-negative at enrollment - You have not previously used cabotegravir - Your doctor thinks injectable PrEP is appropriate for you **You may NOT be eligible if...** - You are currently pregnant or breastfeeding - You have already been diagnosed with HIV - You prefer to continue daily oral PrEP pills rather than switching to injections Talk to your doctor to see if this trial is right for you.